Somatic cell reprogramming for Parkinson's disease treatment
Abstract Parkinson's disease (PD) is a neurodegenerative disease characterized by degeneration of dopamine neurons in the substantia nigra pars compacta. The patient exhibits a series of motor symptoms, such as static tremors, which impair their capacity to take care for themselves in daily lif...
Saved in:
| Main Authors: | Xiaozhuo Li, Kevin Fang, Fengping Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley-VCH
2025-03-01
|
| Series: | Ibrain |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ibra.12189 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Parkinson's disease motor symptoms rescue by CRISPRa‐reprogramming astrocytes into GABAergic neurons
by: Jessica Giehrl‐Schwab, et al.
Published: (2022-04-01) -
Chemical reprogramming ameliorates cellular hallmarks of aging and extends lifespan
by: Lucas Schoenfeldt, et al.
Published: (2025-06-01) -
To recruit or to graft? Comparing the recruitment of resident non-neuronal cells by lineage reprogramming with engraftment of stem cell-derived neurons for neuronal replacement therapies
by: Daniel A. Peterson
Published: (2025-05-01) -
Metabolic landscape uncovers remodeling of T cell immunity affected by fatty acid desaturase in Parkinson’s disease at single-cell resolution
by: Shi Yan, et al.
Published: (2025-08-01) -
Generation and characterisation of seven induced pluripotent stem cell lines from two patients with Parkinson’s disease carrying the pathological variant c.1087G>T of the <i>LGR4</i> gene
by: V. S. Podvysotskaya, et al.
Published: (2025-03-01)